Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Single-cell spatial analysis of tumor immune architecture in diffuse large B cell lymphoma

View ORCID ProfileAnthony Colombo, Monirath Hav, Erik Gerdtsson, Mohan Singh, Alexander Xu, Alicia Gamboa, Denaly Chen, Jane Houldsworth, Rita Shaknovich, Tomohiro Aoki, Lauren Chong, Katsuyoshi Takata, Elizabeth A Chavez, Christian Steidl, James Hicks, Peter Kuhn, Imran Siddiqi, Akil Merchant
doi: https://doi.org/10.1101/2021.02.01.21250775
Anthony Colombo
1Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA
2Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anthony Colombo
Monirath Hav
1Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA
2Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Gerdtsson
3USC Michelson Center for Convergent Biosciences and Department of Biological Sciences, University of Southern California, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohan Singh
3USC Michelson Center for Convergent Biosciences and Department of Biological Sciences, University of Southern California, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Xu
1Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA
2Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alicia Gamboa
1Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA
2Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denaly Chen
4Department of Medicine, University of Southern California, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane Houldsworth
5Cancer Genetics, Inc. Rutherford, NJ
6Department of Pathology, Mount Sinai School of Medicine, New York, NY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rita Shaknovich
5Cancer Genetics, Inc. Rutherford, NJ
7GRAIL, Incorporated, Menlo Park, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomohiro Aoki
8Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia
9Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren Chong
8Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuyoshi Takata
8Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A Chavez
8Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Steidl
8Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia
9Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Hicks
3USC Michelson Center for Convergent Biosciences and Department of Biological Sciences, University of Southern California, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Kuhn
3USC Michelson Center for Convergent Biosciences and Department of Biological Sciences, University of Southern California, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imran Siddiqi
10Department of Pathology, University of Southern California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akil Merchant
1Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA
2Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: akil.merchant{at}cshs.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Multiplexed immune cell profiling of the tumor microenvironment (TME) in cancer has improved our understanding of cancer immunology, but complex spatial analyses of tumor-immune interactions in lymphoma are lacking. Here we used imaging mass cytometry (IMC) on 33 cases of diffuse large B cell lymphoma (DLBCL) to characterize tumor and immune cell architecture and correlate it to clinicopathological features such as cell of origin, gene mutations, and responsiveness to chemotherapy. To understand the poor response of DLBCL to immune check point inhibitors (ICI), we compared our results to IMC data from Hodgkin lymphoma (HL), a cancer highly responsive to ICI, and observed differences in the expression of PD-L1, PD-1, and TIM-3. We created a spatial classification of tumor cells and identified sub-regions of immune activation, immune suppression, and immune exclusion within the topology of DLBCL. Finally, the spatial analysis allowed us to identify markers such as CXCR3, which are associated with penetration of immune cells into immune desert regions, with important implications for engineered cellular therapies.

SIGNIFICANCE This is the first study to integrate tumor mutational profiling, cell of origin classification, and multiplexed immuno-phenotyping of the TME into a spatial analysis of DLBCL at the single cell level. We demonstrate that, far from being histo-pathologically monotonous, DLBCL has a complex tumor architecture, and that changes in tumor topology can be correlated with clinically relevant features. This analysis identifies candidate biomarkers and therapeutic targets such as TIM-3, CCR4, and CXCR3 that are relevant for combination treatment strategies in immuno-oncology and cellular therapies such as CAR-T cells.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project was supported by funding from the Ming Hsieh Institute at University of Southern California to A.M., J.H. and P.K. Additional support for this project was provided by K08 CA154975-01A1 career development award to A.M. from the National Cancer Institute, and a Paul Allen Distinguished Investigator award (Frontiers Group; C. Steidl). Access to the imaging mass cytometry system was obtained through the Fluidigm Early Access Program and support from the USC Michelson CSI-Cancer program. The content is solely the responsibility of the authors and does not necessarily 35 represent the official views of the National Cancer Institute or the National Institute of Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was conducted in accordance with the Declaration of Helsinki. Protocols for tissue and clinical data collection were approved by the USC Health Sciences Institutional Review Board.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

data is public available, and can be used/shared

https://github.com/arcolombo/singleCell_DLBCL

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 03, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Single-cell spatial analysis of tumor immune architecture in diffuse large B cell lymphoma
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Single-cell spatial analysis of tumor immune architecture in diffuse large B cell lymphoma
Anthony Colombo, Monirath Hav, Erik Gerdtsson, Mohan Singh, Alexander Xu, Alicia Gamboa, Denaly Chen, Jane Houldsworth, Rita Shaknovich, Tomohiro Aoki, Lauren Chong, Katsuyoshi Takata, Elizabeth A Chavez, Christian Steidl, James Hicks, Peter Kuhn, Imran Siddiqi, Akil Merchant
medRxiv 2021.02.01.21250775; doi: https://doi.org/10.1101/2021.02.01.21250775
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Single-cell spatial analysis of tumor immune architecture in diffuse large B cell lymphoma
Anthony Colombo, Monirath Hav, Erik Gerdtsson, Mohan Singh, Alexander Xu, Alicia Gamboa, Denaly Chen, Jane Houldsworth, Rita Shaknovich, Tomohiro Aoki, Lauren Chong, Katsuyoshi Takata, Elizabeth A Chavez, Christian Steidl, James Hicks, Peter Kuhn, Imran Siddiqi, Akil Merchant
medRxiv 2021.02.01.21250775; doi: https://doi.org/10.1101/2021.02.01.21250775

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)